Lars Christian Petersen
25Patents
12h-index
36Co-inventors
81Inventor score
Filing activity: Nov 19, 1990 → Jan 9, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5861374A | Modified Factor VII | Chemistry; Metallurgy | 77 | Expired |
| US5833982A | Modified factor VII | Chemistry; Metallurgy | 72 | Expired |
| US5817788A | Modified factor VII | Chemistry; Metallurgy | 64 | Expired |
| US5788965A | Modified factor VII | Chemistry; Metallurgy | 59 | Expired |
| US5576294A | Human Kunitz-type protease inhibitor variant | Human Necessities | 57 | Expired |
| US5373090A | Aprotinin analogues and a process for the production thereof | Human Necessities | 32 | Expired |
| US5629176A | Human Kunitz-type protease inhibitor variants | Human Necessities | 30 | Expired |
| US6183743A | Modified factor VII | Human Necessities | 26 | Expired |
| US5997864A | Modified factor VII | Human Necessities | 25 | Expired |
| US5618696A | Human kunitz-type protease inhibitor and variants thereof | Human Necessities | 23 | Expired |
| US6461610B1 | Methods for modifying cell motility using factor VIIa or inactivated factor VIIa | Physics | 14 | Expired |
| US5859010A | Factor VII -binding reagent | Chemistry; Metallurgy | 13 | Expired |
| US6858587B2 | Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis | Human Necessities | 10 | Expired |
| US5621074A | Aprotinin analogs | Human Necessities | 8 | Expired |
| US6268163A | Identification of drug candidates modulating factor VII-mediated intracellular signaling | Physics | 5 | Expired |
| US9896513B2 | Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitor | Chemistry; Metallurgy | 5 | Active |
| US6039944A | Modified Factor VII | Human Necessities | 5 | Expired |
| US5591603A | Process for preparing aprotinin and aprotinin analogs in yeast cells | Human Necessities | 4 | Expired |
| US5618915A | Aprotinin analogs | Human Necessities | 3 | Expired |
| US9228022B2 | Antibodies that are capable of specifically binding tissue factor pathway inhibitor | Chemistry; Metallurgy | 2 | Active |
| US10106606B2 | Targeting tissue factor to activated platelets | Chemistry; Metallurgy | 0 | Active |
| US7829529B2 | Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis | Human Necessities | 0 | Active |
| US6168789A | Modified factor VII | Chemistry; Metallurgy | 0 | Expired |
| US9260518B2 | Antibodies that are capable of specifically binding tissue factor pathway inhibitor | Chemistry; Metallurgy | 0 | Active |
| US10717784B2 | Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.